Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Merritt

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Bioscience Reports|December 1, 1984
Studies on the involvement of calcium and calmodulin in the action of growth-hormone-releasing factorJ E Merritt, P R Dobson, R J Wojcikiewicz, et al.
Biochemical Society Transactions|November 1, 1993
Definition of early Ca2+ signals induced by anti-CD3 antibody in a human Jurkat T-cell line using a selective protein kinase C inhibitor, Ro 31-8425L A Conroy, J E Merritt, C F Giafi, et al.
European Journal of Immunology|March 1, 1994
Effect of a selective protein kinase C inhibitor, Ro 31-8425, on Mac-1 expression and adhesion of human neutrophilsJ A Sullivan, J E Merritt, J M Budd, et al.
Clinical Science (London, England : 1979)|May 1, 1984
Calmodulin and cell functionS Tomlinson, S MacNeil, S W Walker, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|July 1, 1993
Chemical study of the hepatotoxins from Microcystis aeruginosa collected in CaliforniaS E DeVries, M Namikoshi, F D Galey, et al.
The Biochemical Journal|February 1, 1993
Involvement of calcium in modulation of neutrophil function by phorbol esters that activate protein kinase C isotypes and related enzymesJ E Merritt, K E Moores, A T Evans, et al.
Cancer Chemotherapy and Pharmacology|April 1, 1999
The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cellsJ E Merritt, J A Sullivan, L Drew, et al.
British Journal of Pharmacology|January 1, 1991
Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptorJ E Merritt, T J Hallam, A M Brown, et al.
British Journal of Pharmacology|January 1, 1991
Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptorJ E Merritt, A M Brown, S Bund, et al.
The Biochemical Journal|October 15, 1990
SK&F 96365, a novel inhibitor of receptor-mediated calcium entryJ E Merritt, W P Armstrong, C D Benham, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Bioscience Reports|December 1, 1984
Studies on the involvement of calcium and calmodulin in the action of growth-hormone-releasing factorJ E Merritt, P R Dobson, R J Wojcikiewicz, et al.
Biochemical Society Transactions|November 1, 1993
Definition of early Ca2+ signals induced by anti-CD3 antibody in a human Jurkat T-cell line using a selective protein kinase C inhibitor, Ro 31-8425L A Conroy, J E Merritt, C F Giafi, et al.
European Journal of Immunology|March 1, 1994
Effect of a selective protein kinase C inhibitor, Ro 31-8425, on Mac-1 expression and adhesion of human neutrophilsJ A Sullivan, J E Merritt, J M Budd, et al.
Clinical Science (London, England : 1979)|May 1, 1984
Calmodulin and cell functionS Tomlinson, S MacNeil, S W Walker, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|July 1, 1993
Chemical study of the hepatotoxins from Microcystis aeruginosa collected in CaliforniaS E DeVries, M Namikoshi, F D Galey, et al.
The Biochemical Journal|February 1, 1993
Involvement of calcium in modulation of neutrophil function by phorbol esters that activate protein kinase C isotypes and related enzymesJ E Merritt, K E Moores, A T Evans, et al.
Cancer Chemotherapy and Pharmacology|April 1, 1999
The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cellsJ E Merritt, J A Sullivan, L Drew, et al.
British Journal of Pharmacology|January 1, 1991
Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptorJ E Merritt, T J Hallam, A M Brown, et al.
British Journal of Pharmacology|January 1, 1991
Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptorJ E Merritt, A M Brown, S Bund, et al.
The Biochemical Journal|October 15, 1990
SK&F 96365, a novel inhibitor of receptor-mediated calcium entryJ E Merritt, W P Armstrong, C D Benham, et al.
Pageof 6